-
Virtual Twins: Their Roles In Healthcare, Drug Discovery, And Pandemic Response
Jul 9, 2020, 10:10 AM by Michael CroftFull storyBio-IT World | In a world that has shifted to virtual everything—work, recreation, connection—it’s no wonder that virtual or digital twins are getting more attention. It’s certainly a favorite term of marketers: we are creating digital twins for everything from people to businesses, instruments to labs.
-
HENRY SCHEIN MEDICAL ANNOUNCES EXPANSION OF MEDPOD’S TELEMEDICINE SOLUTIONS WITH INTEGRATION OF VISUALDX
Jul 9, 2020, 10:02 AM by Michael CroftMELVILLE, NY, UNITED STATES - Jul 9, 2020 - Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. and exclusive distributor of Medpod, IncFull story -
SCL Health Partners with Kyruus to Enhance Consumer and Provider Experience
Jul 8, 2020, 11:17 AM by Michael CroftBOSTON, MA, UNITED STATES - Jul 8, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, and SCL Health, a faith-based nonprofit health system providing care across Colorado, Kansas, and Montana, today announced that SCL Health has selected Kyruus patient access and provider data management platform to enable its digital access initiativesFull story -
Absolute Antibody and University of Zurich Collaborate to Offer Synthetic Nanobodies Against SARS-CoV-2 Receptor Binding Domain
Jul 8, 2020, 09:53 AM by Michael CroftREDCAR, UNITED KINGDOM - Jul 8, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with University of Zurich to offer synthetic nanobodies against the receptor binding domain (RBD) of SARS-CoV-2, the coronavirus that causes COVID-19Full story -
Can Your Data Protection Strategy Survive A Pandemic?
Jul 8, 2020, 08:15 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Across the world, scientific laboratories have redirected their research efforts toward the global COVID-19 pandemic. Achieving the goal of understanding and treating the virus requires the generating and gathering of data. Like any big shift in the way we generate, manage, or use data, this will have implications for the datacenter.
-
Optibrium and North Carolina School of Science and Mathematics mark five years of education collaboration with summer school ‘Computing COVID-19’
Jul 8, 2020, 06:01 AM by Michael CroftCAMBRIDGE, UK AND DURHAM, NC, USA, UNITED KINGDOM - Jul 8, 2020 - Optibrium, a leading provider of software and services for drug discovery, and the North Carolina School of Science and Mathematics (NCSSM), the states leading high school for science, technology and math education, are celebrating five years of an education support collaborationFull story -
Boehringer Ingelheim Extends TrialScope Partnership
Jul 7, 2020, 12:05 PM by Michael CroftJERSEY CITY, NJ, UNITED STATES - Jul 7, 2020 - In its ongoing commitment to maintaining compliance with ever-changing global clinical trial disclosure regulations, Boehringer Ingelheim has renewed its partnership with TrialScope for an additional five yearsFull story -
InSysBio to announce the launch of its new tool Heta compiler
Jul 7, 2020, 05:04 AM by Michael CroftMOSCOW, RUSSIA - Jul 6, 2020 - InSysBio, one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents Heta compiler which is a tool for the development of Quantitative Systems Pharmacology and Systems Biology platformsFull story -
OPTRONICS Releases New Visual Inspection Tools Now Available on GSA Contract.
Jul 6, 2020, 17:12 PM by Michael CroftGOLETA, CA, UNITED STATES - Jul 6, 2020 - FOR IMMEDIATE RELEASEFull story
OPTRONICS Releases New Visual Inspection Tools Now Available on GSA Contract -
Bio-IT World Announces 2020 Innovative Practices Award Winners
Jul 6, 2020, 09:00 AM by Michael CroftFull storyBio-IT World | Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance have been announced as the winners of the 2020 Innovative Practices Awards.
-
How The SARS-CoV-19 Virus Attacks Cells, Other COVID-19 News
Jul 2, 2020, 08:25 AM by Michael CroftFull storyBio-IT World | New research shows how the SARS-CoV-19 virus shifts the cell's activity to promote its own replication and to infect nearby cells. This, plus more, are featured in this week’s COVID-19 news from the biotech and research industries.
-
Kyruus Obtains AVIA Recognition for Its Enterprise-Wide Patient Access Platform
Jul 1, 2020, 11:36 AM by Michael CroftBOSTON, MA, UNITED STATES - Jul 1, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that AVIA, the nation's leading digital transformation partner for healthcare organizations, has recognized its full suite of technology solutions with AVIA Vetted and/or Market Validated designations for 2020Full story -
Saving Lives with Great Research Requires a Research Tech Rethink
Jul 1, 2020, 08:10 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Researchers are working hard to provide the evidence needed for fact-based decisions addressing everything from developing new vaccines, to ensuring existing treatments are being used to their best advantage. Now, more than ever, the time and funding allocated for these projects must be used to their fullest extent.
-
Creative Diagnostics Expands Response to COVID-19 to Recombinant SARS-CoV-2 RBD Mutants
Jul 1, 2020, 03:41 AM by Michael CroftNEW YORK, NY, UNITED STATES - Jul 2, 2020 - As COVID-19 is still spreading all over the world, the global confirmed cases have jumped to 9 millionFull story -
CD Bioparticles: A Trustworthy Provider of All Sorts of PEG Conjugations
Jul 1, 2020, 03:38 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 1, 2020 - Polyethylene glycol (PEG), a biocompatible, synthetic, hydrophilic polyether compound, is non-toxic, FDA-approved, and is frequently used in many biomedical applications including bioconjugation, drug delivery, surface functionalization, and tissue engineeringFull story -
Creative Biolabs Updated Exosome Isolation and Profiling Service to Facilitate Related Research
Jun 30, 2020, 23:11 PM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 1, 2020 - Recently, exosomes, which have specialized functions and play a key role in different physiological processes and pathological conditions, are attracting increasing attention in their clinical applications for prognosis, diagnosis, drug delivery, and vaccine developmentFull story -
Kyruus Achieves SOC 2 Type II Attestation
Jun 29, 2020, 11:31 AM by Michael CroftBOSTON, MA, UNITED STATES - Jun 29, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that it has successfully completed its System and Organization Controls (SOC) 2 Type II examination by an independent auditorFull story -
Genomics England launches next-generation research platform central to UK COVID-19 response
Jun 29, 2020, 09:15 AM by Michael CroftLONDON, UK - Jun 29, 2020 - Genomics England (GEL) has today launched a next-generation genomic research platform that will play a key role in the research response to COVID-19Full story -
Bringing Light—and Value—to Dark Data in Research & Design
Jun 29, 2020, 08:35 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Data are often recognized as a top asset of organizations in any field, including the biosciences, but the way it’s handled may not adequately reflect this. One explanation for this mismatch is that the amount of data being produced every day is enormous—but not necessarily accessible.
-
AI & Medicine Releases Biomarker Discovery and Targeted Proteomics Services for Researchers
Jun 29, 2020, 04:58 AM by Michael CroftNY, NY, UNITED STATES - Jun 23, 2020 - As an expert in the field of AI-Powered drug discovery, personalized healthcare and various medical applications, the New York-based company AI & Medicine recently announces to release biomarker discovery and targeted proteomics services for researchers worldwideFull story